Abstract: In a push back cart rack storage system, the top or first cart, as well as the second cart, may be made with less material, and may be significantly simpler and lighter in comparison to existing designs. A push-back cart storage system has a single pair of push-back rails in each lane. A third cart has front and back wheels rolling on a lower inside flange of the push-back rails. A second cart has front wheels rolling on a lower inside cart flange of side rails of the third cart, and has rear wheels rolling on the lower inside flange of the push-back rails. A first or top cart has front and rear wheels rolling on a top surface of the push-back rails. The wheels on the first cart may be inner facing wheels while the wheels on the other carts may be outer facing wheels. The push-back rails and the side rails of the carts may be generally C-shaped channel sections.

Abstract: A drive-in rail attachment or arm attaches left and right side drive-in rails to left and right side uprights in a drive-in storage rack. The left and right side rail arms may each be formed from a flat plate having an upright section, a sidewall section and a rail section. The upright section may be bent about a first axis to an orientation substantially perpendicular to the sidewall section and the rail section bent about a second axis to an orientation substantially perpendicular to the sidewall section. First and second pairs of holes may be provided in the upright section, with the first pair of holes optionally offset from the second pair of holes. Drive-in rails can be attached to the storage rack without the need for welded components.

Abstract: A push-back cart storage system has one or more push-back carts having a cross-member formed by a structural angle section having cutouts at opposite ends to provide clearance for the second push-back cart to move under the first push-back cart. The cross member provides a truss or joist type of beam support having a full height middle section which resists bending and a reduced height at the ends, to provide a low profile. Side members or angle sections on the cart have through holes for attaching wheels, with no welding of wheel mounts required.

Abstract: In a push back cart rack storage system, the top or first cart, as well as the second cart, may be made with less material, and may be significantly simpler and lighter in comparison to existing designs. A push-back cart storage system has a single pair of push-back rails in each lane. A third cart has front and back wheels rolling on a lower inside flange of the push-back rails. A second cart has front wheels rolling on a lower inside cart flange of side rails of the third cart, and has rear wheels rolling on the lower inside flange of the push-back rails. A first or top cart has front and rear wheels rolling on a top surface of the push-back rails. The wheels on the first cart may be inner facing wheels while the wheels on the other carts may be outer facing wheels. The push-back rails and the side rails of the carts may be generally C-shaped channel sections.

Abstract: A drive-in rail attachment or arm attaches left and right side drive-in rails to left and right side uprights in a drive-in storage rack. The left and right side rail arms may each be formed from a flat plate having an upright section, a sidewall section and a rail section. The upright section may be bent about a first axis to an orientation substantially perpendicular to the sidewall section and the rail section bent about a second axis to an orientation substantially perpendicular to the sidewall section. First and second pairs of holes may be provided in the upright section, with the first pair of holes optionally offset from the second pair of holes. Drive-in rails can be attached to the storage rack without the need for welded components.

Abstract: A push-back cart storage system has one or more push-back carts having a cross-member formed by a structural angle section having cutouts at opposite ends to provide clearance for the second push-back cart to move under the first push-back cart. The cross member provides a truss or joist type of beam support having a full height middle section which resists bending and a reduced height at the ends, to provide a low profile. Side members or angle sections on the cart have through holes for attaching wheels, with no welding of wheel mounts required.

Abstract: A push-back storage system includes left and right rails welded to strut members, to provide a precise predetermined spacing between the rails. As the spacing between rails is permanently set during manufacture, no on site adjustment or alignment is needed. Carts can roll smoothly on the rails as the spacing between the rails is maintained. A U-bracket or a J-hook at the front of the bedframe facilitates attachment of the bedframe to a front load beam of a rack assembly. The strut members are welded to the rails.

Abstract: The present invention relates to the chemical products of general formula: ##STR1## in which R.sub.1 and R.sub.2 designate hydrogen; halogen, lower alkyl or lower alkoxy; R.sub.3 and R.sub.4 designate hydrogen, alkyl, alkoxy, halogen, nitro, acyl, alkylthio, alkylsulfinyl, alkylsulfonyl, a (CH.sub.2).sub.n COOR, (CH.sub.2).sub.2 CONHR, (CH.sub.2).sub.n NHCOOR or (CH.sub.2).sub.n NHCOR group; or R.sub.3 and R.sub.4 together form a heterocycle bonded to the benzene cycle; X.sub.1 is hydrogen, alkyl, hydroxymethyl or COOR and X.sub.2 is hydrogen or methyl; and to the pharmaceutically acceptable salts of said products. It also relates to a process for preparing said products and to the drugs active in particular on the cardiovascular system, containing at least one of said products.

Abstract: The present invention relates to new pyridine derivatives of formula: ##STR1## wherein R.sub.1 is an alkyl or an alicyclic group, R.sub.2 and R.sub.3 are alkyls or alicyclic groups or form an heterocycle with the atom of nitrogen to which they are bonded; the invention also relates to a process for the preparation of said derivatives and the medicines containing at least one of the said derivatives.

Abstract: Carcinostatic products are formed by coupling, by covalent bonding, the A chain of ricin with an antibody which is capable of selectively recognizing a given antigen at the surface of cancerous cells. Such products can be made by the formation of a disulphide bridge between the free thiol group in the A chain of ricin and an immunoglobulin or immunoglobulin fragment into which a thiol group or an activated disulphide group has been introduced. The A chain of ricin and the immunoglobulin are carefully purified before use.

Abstract: The present invention relates to a new process for the stepwise preparation of somatostatin enabling a product of high purity to be obtained, with high yields, from cysteine in 14 position whose acid function is protected by the phenylazobenzylsulfonylethyloxy group and thiol function is protected by the acetamidomethyl group, all the peptide coupling reactions being effected in liquid phase in the dimethylformamide, the intermediate peptides being precipitated by addition of a second solvent and purified in solid phase by washing with the aid of suitable solvents dissolving the impurities.

Abstract: The present invention relates to phenoxypropane having the formula ##STR1## in which R.sup.1 and R.sup.2 are like or unlike and each is an alkyl group having 1-4 carbon atoms, R.sup.3 is hydrogen or an alkyl group having 1-4 carbon atoms, R.sup.4 is a halogen atom, preferably fluorine, chlorine or bromine, including their optical isomers and also their addition salts with acids.These compounds are of therapeutic value in the treatment of cardiovascular conditions.The invention also relates to methods of synthesis of these products including a synthesis which involves the production, as a intermediate of an 8-aza-4,9-dioxa-2,3-benzo-bicyclo-[4,2,1]-octane having the formula ##STR2## in which R.sup.1 and R.sup.4 are as above defined.

Abstract: Talampicillin 2-methoxyphenoxyacetate; a process for its preparation by acid hydrolysis of the metampicillin phthalidyl ester in a biphasic aqueous-organic solvent and treatment of the resulting aqueous phase with an alkali metal salt of the 2-methoxyphenoxyacetic acid; and pharmaceutical compositions containing said talampicillin 2-methoxyphenoxyacetate as an active ingredient.

Abstract: A process and device for processing and displaying an electrocardiogram signal read at a speed greater than the speed of recording, in which process a plurality of types of pathological complexes are selectively and simultaneously detected with the aid of discriminators on the signal read, and on each of a plurality of distinct display locations there is displayed each signal sequence presenting a complex of a type corresponding to said display location. The process and device are more particularly applicable to the statistical processing such as the drawing up of a histogram of the pathological occurrences of an electrocardiogram signal.

Abstract: Compositions having therapeutic value in the treatment of cardiovascular conditions associated with the overproduction of catecholamines include as the active ingredient 5-fluoro-2-(2-hydroxy-3-tertiary butyl-amino-propoxy) butyrophenone-, its optical isomers and non-toxic acid addition salts.

Abstract: The present invention relates to a process for the treatment of secondary frigidity wherein between 100 and 300 mg of 3-morpholinoethylamino 4-methyl 6-phenylpyridazine are administered daily to the patient by oral route.

Abstract: The invention relates to benzodiazepine compounds of the formula: ##STR1## wherein R.sub.5 is C.sub.1 -C.sub.4 alkyl, R.sub.3 is C.sub.1 -C.sub.4 alkyl, and R.sub.4 is selected from Cl and F, and medicaments containing such benzodizepine compounds.

Abstract: The present invention relates to a treatment of the "hyperkinetic syndrome" in children, wherein a medicine containing between 50 and 200 mg of 3-morpholino-ethylamino 4-methyl 6-phenylpyridazine is administered daily to patients, by oral route.

Abstract: Novel derivatives of midecamycine, of the formula: ##STR1## wherein X represents an oxygen atom or a sulphur atom, R.sub.1 represents a straight or branched alkyl group, an alkenyl group or an aryl group, R.sub.2 represents a hydrogen atom or a lower acyl group, the dotted lines represent the possible presence of double bonds, it being understood that the 2 double bonds at the 10,11 position on the one hand and the 12,13 position on the other either exist simultaneously or neither of them exists, which give by oral administration plasma rates which are higher than midecamycine and which lack its bitter taste, together with their process of preparation.

Abstract: Compounds having psychostimulant, antispasmodic, hypotensive and analgesic properties are disclosed. The compounds have the formula: ##STR1## in which R.sup.2 is selected from the group consisting of a hydrogen atom and a halogen atom;R.sup.1 is selected from the group consisting of a cyclohexyl group and a phenyl group, and is a cyclohexyl group when R.sup.2 is a halogen atom;A is selected from the group consisting of CH.sub.2 CH.sub.2 and CH.dbd.CH groups; andNr.sup.3 r.sup.4 is selected from the group consisting of an alkylamino group, a dialkylamino group and a heterocyclic ring containing from 5 to 7 atoms in the ring, said ring optionally having one or more sbustituents and optionally containing a second hetero-atom; and acid addition salts of said compounds.